EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lacticaseibacillus rhamnosus MS27 Potentially Prevents Ulcerative Colitis Through Modulation of Gut Microbiota

Jie Zhang iD, Jiakun Shen, Linbao Ji, Peng Tan, Chunchen Liu iD, Xiujun Zhang, Xi Ma iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jie Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, North China University of Science and Technology, Tangshan 063210, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Lacticaseibacillus rhamnosus, Probiotics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1) This study explored Lacticaseibacillus rhamnosus MS27, a newly isolated strain, as a potential probiotic candidate for alleviating the onset and severity of ulcerative colitis (UC). (2) L. rhamnosus MS27 was isolated and subjected to biochemical identification, antibiotic sensitivity testing, and antibacterial activity assessment. Dextran sulfate sodium (DSS) colitis model mice were used to evaluate its alleviating effects. In this study, 16S rRNA microbiome and eukaryotes reference transcriptome analyses were conducted to investigate its impact on intestinal microbial ecology and potential molecular mechanisms. (3) L. rhamnosus MS27 exhibits high acid tolerance at pH 3.23 and maintains a high viable bacterial count for 24 h. It can utilize sucrose, lactose, maltose, inulin, esculin, salicin, and mannitol but not raffinose, and it is sensitive to carbenicillin, erythromycin, tetracycline, chloramphenicol, clindamycin, and penicillin. It effectively increases the abundance of beneficial microbes, particularly Akkermansia, Muribaculaceae, and Limosilactobacillus reuteri (p < 0.05), while significantly reducing microorganisms linked to human pathogens causing diarrhea and gastroenteritis (p < 0.05). Transcriptomic analysis demonstrated that the expression levels of Igkv16-104 and C1qtnf3 were significantly downregulated in the presence of L. rhamnosus MS27 treatment compared to DSS treatment alone (p < 0.05). Further analysis revealed significant differences in genes related to immune functions, antigen presentation, and immune cell markers, indicating potential protein–protein interaction networks, particularly among genes of the major histocompatibility complex (MHC). (4) L. rhamnosus MS27, as a novel strain, demonstrates a significant capacity to alleviate inflammatory phenotypes. L. rhamnosus MS27 exhibits distinctive metabolic characteristics in lactic acid utilization, acetic acid and oleic acid production. Furthermore, it contributes to systemic homeostasis regulation by modulating Turicibacter to link intestinal microbiota composition with host immune function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeGastrointestinal MicrobiomeLacticaseibacillus rhamnosusProbioticsAnimalsMiceRNA, Ribosomal, 16SDisease Models, AnimalDextran SulfateMale

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosusimmune responsesmicrobiotaprobioticstranscriptomic profilesulcerative colitis

Substanzen

RNA, Ribosomal, 16SDextran Sulfate

Autor:innen und Institutionen

  • School of Public Health, North China University of Science and Technology, Tangshan 063210, China.
  • State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China.

ORCID-Profile: Jie Zhang, Chunchen Liu, Xi Ma

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • 2115 Talent Development Program of China Agricultural University

Zitieren

APA

Zhang, J., Shen, J., Ji, L., Tan, P., Liu, C., Zhang, X., & Ma, X. (2025). Lacticaseibacillus rhamnosus MS27 Potentially Prevents Ulcerative Colitis Through Modulation of Gut Microbiota. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311397

Vancouver

Zhang J, Shen J, Ji L, Tan P, Liu C, Zhang X, et al. Lacticaseibacillus rhamnosus MS27 Potentially Prevents Ulcerative Colitis Through Modulation of Gut Microbiota. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311397

BibTeX
@article{Zhang2025,
  author = {Zhang, Jie and Shen, Jiakun and Ji, Linbao and Tan, Peng and Liu, Chunchen and Zhang, Xiujun and Ma, Xi},
  title = {Lacticaseibacillus rhamnosus MS27 Potentially Prevents Ulcerative Colitis Through Modulation of Gut Microbiota},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311397}
}
Kostenlos starten →